# DiaMedica Therapeutics Inc.: filings

DMAC · Nasdaq · CIK 1401040 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dmac.md) · [Financials](/companies/dmac/financials.md) · [Filings](/companies/dmac/filings.md) · [Insiders](/companies/dmac/insiders.md)

## Reports and events: 125 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 153, 8-K 80, 10-Q 23, 3 23, UPLOAD 13, CORRESP 12, SC 13G/A 12, SC 13G 10, EFFECT 9, 10-K 8, DEF 14A 8, DEFA14A 8, S-3 8, SCHEDULE 13G/A 8, S-8 7, D 6, 424B5 4, ARS 4, 424B3 3, DRSLTR 3, S-1/A 3, CT ORDER 2, DRS 2, DRS/A 2, PRE 14A 2, 10-K/A 1, 144 1, 20FR12B 1, 20FR12B/A 1, 424B2 1, 424B4 1, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, CERT 1, RW 1, S-1 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 16:37 ET | [10-Q](/filings/0001437749-26-026792.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026792 |
| 2026-08-10 | 16:35 ET | [8-K](/filings/0001437749-26-026790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026790 |
| 2026-05-21 | 16:30 ET | [8-K](/filings/0001437749-26-018106.md) | 5.07 Shareholder vote results | 0001437749-26-018106 |
| 2026-05-06 | 16:38 ET | [10-Q](/filings/0001437749-26-015220.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015220 |
| 2026-05-06 | 16:36 ET | [8-K](/filings/0001437749-26-015218.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-015218 |
| 2026-04-01 | 16:06 ET | [DEF 14A](/filings/0001437749-26-010879.md) | Proxy statement, period 2026-05-20 | 0001437749-26-010879 |
| 2026-03-31 | 18:40 ET | [8-K](/filings/0001437749-26-010409.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010409 |
| 2026-03-30 | 17:34 ET | [10-K](/filings/0001437749-26-010342.md) | Annual report, period 2025-12-31 | 0001437749-26-010342 |
| 2026-01-05 | 09:15 ET | [8-K](/filings/0001437749-26-000175.md) | 8.01 Other events | 0001437749-26-000175 |
| 2025-12-18 | 08:45 ET | [8-K](/filings/0001437749-25-038211.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038211 |
| 2025-11-12 | 16:33 ET | [10-Q](/filings/0001437749-25-034469.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034469 |
| 2025-11-12 | 16:31 ET | [8-K](/filings/0001437749-25-034467.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034467 |
| 2025-08-12 | 17:27 ET | [8-K](/filings/0001437749-25-026286.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-026286 |
| 2025-08-12 | 16:17 ET | [10-Q](/filings/0001437749-25-026207.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026207 |
| 2025-08-12 | 16:15 ET | [8-K](/filings/0001437749-25-026205.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026205 |
| 2025-08-06 | 08:00 ET | [8-K](/filings/0001437749-25-024956.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-024956 |
| 2025-07-21 | 08:01 ET | [8-K](/filings/0001437749-25-023048.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-023048 |
| 2025-07-17 | 08:05 ET | [8-K](/filings/0001437749-25-022877.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-022877 |
| 2025-05-15 | 16:46 ET | [8-K](/filings/0001437749-25-017239.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-017239 |
| 2025-05-13 | 16:31 ET | [10-Q](/filings/0001437749-25-016488.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016488 |
| 2025-05-13 | 16:30 ET | [8-K](/filings/0001437749-25-016487.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016487 |
| 2025-03-28 | 07:14 ET | [DEF 14A](/filings/0001437749-25-009696.md) | Proxy statement, period 2025-05-15 | 0001437749-25-009696 |
| 2025-03-17 | 16:32 ET | [10-K](/filings/0001437749-25-008018.md) | Annual report, period 2024-12-31 | 0001437749-25-008018 |
| 2025-03-17 | 16:30 ET | [8-K](/filings/0001437749-25-008014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008014 |
| 2025-03-06 | 08:30 ET | [8-K](/filings/0001437749-25-006379.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-006379 |
| 2025-02-24 | 16:30 ET | [8-K](/filings/0001437749-25-004891.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-004891 |
| 2024-11-13 | 16:22 ET | [10-Q](/filings/0001437749-24-034925.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034925 |
| 2024-11-13 | 16:21 ET | [8-K](/filings/0001437749-24-034922.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-034922 |
| 2024-08-07 | 16:32 ET | [8-K](/filings/0001437749-24-025200.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025200 |
| 2024-08-07 | 16:31 ET | [10-Q](/filings/0001437749-24-025198.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025198 |
| 2024-06-26 | 08:16 ET | [8-K](/filings/0001437749-24-021220.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-021220 |
| 2024-06-26 | 08:01 ET | [8-K](/filings/0001437749-24-021219.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-021219 |
| 2024-05-23 | 16:00 ET | [8-K](/filings/0001437749-24-018140.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-018140 |
| 2024-05-08 | 16:34 ET | [10-Q](/filings/0001437749-24-015381.md) | Quarterly report, period 2024-03-31 | 0001437749-24-015381 |
| 2024-05-08 | 16:30 ET | [8-K](/filings/0001437749-24-015378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-015378 |
| 2024-04-10 | 16:36 ET | [8-K](/filings/0001437749-24-011645.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-011645 |
| 2024-04-04 | 06:05 ET | [DEF 14A](/filings/0001437749-24-010985.md) | Proxy statement, period 2024-05-22 | 0001437749-24-010985 |
| 2024-03-19 | 16:17 ET | [10-K](/filings/0001437749-24-008522.md) | Annual report, period 2023-12-31 | 0001437749-24-008522 |
| 2024-03-19 | 16:16 ET | [8-K](/filings/0001437749-24-008521.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-008521 |
| 2023-11-13 | 16:55 ET | [10-Q](/filings/0001437749-23-031671.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031671 |
| 2023-11-13 | 16:52 ET | [8-K](/filings/0001437749-23-031669.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-031669 |
| 2023-09-05 | 16:15 ET | [8-K](/filings/0001437749-23-025203.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-23-025203 |
| 2023-08-14 | 16:29 ET | [10-Q](/filings/0001437749-23-023708.md) | Quarterly report, period 2023-06-30 | 0001437749-23-023708 |
| 2023-08-14 | 16:25 ET | [8-K](/filings/0001437749-23-023698.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-023698 |
| 2023-06-21 | 08:42 ET | [8-K](/filings/0001437749-23-017922.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-017922 |
| 2023-06-21 | 08:25 ET | [8-K](/filings/0001437749-23-017917.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-017917 |
| 2023-06-21 | 08:16 ET | [8-K](/filings/0001437749-23-017914.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-017914 |
| 2023-05-30 | 08:30 ET | [8-K](/filings/0001437749-23-016029.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-016029 |
| 2023-05-22 | 17:01 ET | [8-K](/filings/0001437749-23-015488.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-015488 |
| 2023-05-18 | 16:30 ET | [8-K](/filings/0001437749-23-015120.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-015120 |

Page 1 of 3. [Older](/companies/dmac/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.